company

IMMUNOR AS

0349 OSLO

Return on Equity
12,23 %
Current Ratio
0,2
Debt-to-Equity Ratio
−0,96
Key figures (NOK)2021
Revenue305 000
Net Income−223 000
Total Assets177 000
Total Equity−1 824 000
Income (NOK)2021
Revenue305 000
Expenditure567 000
Operating Profit−262 000
Financial Income39 000
Financial Costs0
Financial Balance39 000
Earnings Before Tax−223 000
Tax0
Net Income−223 000
Balance (NOK)2021
Total Fixed Assets127 000
Total Current Assets50 000
Total Assets177 000
Total Retained Equity−1 849 000
Total Equity−1 824 000
Total Long-Term Debt1 752 000
Total Current Debt249 000
Total Equity and Debt177 000
Cash flow (NOK)2021
Sales Income305 000
Other Income0
Revenue305 000
Cost of Goods Sold0
Salary Costs74 000
Depreciation0
Impairment0
Expenditure567 000
Operating Profit−262 000
Financial Income39 000
Financial Costs0
Financial Balance39 000
Dividends0
Net Income−223 000
Balance details (NOK)2021
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets127 000
Total Fixed Assets127 000
Stock0
Total Investments0
Cash, Bank50 000
Total Current Assets50 000
Total Assets177 000
Total Equity−1 824 000
Short-Term Group Debt0
Total Long-Term Debt1 752 000
Creditors209 000
Unpaid Taxes3 000
Dividends0
Other Current Debt37 000
Total Current Debt249 000
Total Equity and Debt177 000
Financial indicators2021
Return on Equity12,23 %
Debt-to-Equity Ratio−0,96
Operating Profit Margin−85,9 %
Current Ratio0,2
Quick Ratio0,2
Equity Ratio−10,31
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English